Earnings Call · Q2 FY2023·2023-08-03

Q2 23EPS +5.88%·Rev n/aQ1 23EPS -18.75%·Rev n/aQ4 22EPS +21.74%·Rev n/aQ3 22EPS +8.00%·Rev n/a⚠ consensus missing

Vaxart, Inc. VXRT

Brant Biehn — Investor Relations or Communications Host

Andrei Floroiu — Chief Executive Officer

James Cummings — Chief Medical Officer

Phil Lee — Chief Financial Officer

+2.6%1d on move date+3.1% vs SPY3d−3.1%5d−4.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VXRT calls or request research access.

More VXRT calls Browse calls Request research access